11 Analysts Have This to Say About Thermo Fisher Scientific
Portfolio Pulse from Benzinga Insights
Within the last quarter, 11 analysts have rated Thermo Fisher Scientific (NYSE:TMO), with 4 being bullish and 7 somewhat bullish. There were no indifferent, somewhat bearish, or bearish ratings. The average 12-month price target for TMO is $573.82, with a high of $630.00 and a low of $515.00, representing a 7.7% decrease from the previous target of $621.70. Analyst ratings are derived from various sources including company calls, financial statements, and insider information, and are used to guide investors on stock performance.
December 11, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Analysts have given Thermo Fisher Scientific mostly positive ratings with an average price target of $573.82, which is a 7.7% decrease from the previous target.
The overall positive ratings from analysts suggest confidence in TMO's performance, but the decrease in the average price target may indicate a tempered expectation for growth. This could lead to a neutral short-term impact on the stock as the market digests both the positive ratings and the lower price target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100